Skip to content

Clinical trials

Completed Phase 2/3 Liver Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 2/3 Status: Completed Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20081
20161
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eastern Hepatobiliary Surgery Hospital1
Mayo Clinic1
Northwestern University1
Radboud University Medical Center1
Shanghai Zhongshan Hospital1
University of Michigan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases6
Hepatomegaly2
Polycystic Kidney, Autosomal Dominant2
Abdominal Pain1
Adenocarcinoma1
Carcinoma, Hepatocellular1
Digestive System Diseases1
Digestive System Neoplasms1
Fibrosis1
Gastrointestinal Neoplasms1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.